• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化肝脏的磁共振成像:肝细胞癌的诊断及治疗反应评估 - 第1部分

Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.

作者信息

Ramalho Miguel, Matos António P, AlObaidy Mamdoh, Velloni Fernanda, Altun Ersan, Semelka Richard C

机构信息

Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, and Hospital Garcia de Orta, Almada, Portugal.

Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, and King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

出版信息

Radiol Bras. 2017 Jan-Feb;50(1):38-47. doi: 10.1590/0100-3984.2015.0132.

DOI:10.1590/0100-3984.2015.0132
PMID:28298731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5347502/
Abstract

Magnetic resonance imaging (MRI) is the modern gold standard for the noninvasive evaluation of the cirrhotic liver. The combination of arterial phase hyperenhancement and delayed wash-out allows a definitive diagnosis of hepatocellular carcinoma (HCC) in patients with liver cirrhosis or chronic liver disease, without the requirement for confirmatory biopsy. That pattern is highly specific and has been endorsed in Western and Asian diagnostic guidelines. However, the sensitivity of the combination is relatively low for small HCCs. In this two-part review paper, we will address MRI of the cirrhotic liver. In this first part, we provide a brief background on liver cirrhosis and HCC, followed by descriptions of imaging surveillance of liver cirrhosis and the diagnostic performance of the different imaging modalities used in clinical settings. We then describe some of the requirements for the basic MRI technique, as well as the standard MRI protocol, and provide a detailed description of the appearance of various types of hepatocellular nodules encountered in the setting of the carcinogenic pathway in the cirrhotic liver, ranging from regenerative nodules to HCC.

摘要

磁共振成像(MRI)是对肝硬化肝脏进行无创评估的现代金标准。动脉期强化和延迟洗脱相结合能够确诊肝硬化或慢性肝病患者的肝细胞癌(HCC),无需进行确诊性活检。这种模式具有高度特异性,已得到西方和亚洲诊断指南的认可。然而,对于小肝癌,这种联合方法的敏感性相对较低。在这篇分两部分的综述文章中,我们将探讨肝硬化肝脏的MRI。在第一部分中,我们简要介绍肝硬化和HCC的背景知识,接着描述肝硬化的影像学监测以及临床中使用的不同成像方式的诊断性能。然后,我们阐述基本MRI技术的一些要求以及标准MRI方案,并详细描述在肝硬化肝脏致癌途径中遇到的各种类型肝细胞结节的表现,从再生结节到HCC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/d3083db22828/rb-50-01-0038-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/41c9c4750fd4/rb-50-01-0038-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/48f2c2d29957/rb-50-01-0038-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/dc65168e76ee/rb-50-01-0038-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/3073c9daf18a/rb-50-01-0038-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/e3c00da35a68/rb-50-01-0038-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/5c8bc9ae5206/rb-50-01-0038-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/26e0c83c8490/rb-50-01-0038-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/d3083db22828/rb-50-01-0038-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/41c9c4750fd4/rb-50-01-0038-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/48f2c2d29957/rb-50-01-0038-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/dc65168e76ee/rb-50-01-0038-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/3073c9daf18a/rb-50-01-0038-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/e3c00da35a68/rb-50-01-0038-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/5c8bc9ae5206/rb-50-01-0038-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/26e0c83c8490/rb-50-01-0038-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ba/5347502/d3083db22828/rb-50-01-0038-g08.jpg

相似文献

1
Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.肝硬化肝脏的磁共振成像:肝细胞癌的诊断及治疗反应评估 - 第1部分
Radiol Bras. 2017 Jan-Feb;50(1):38-47. doi: 10.1590/0100-3984.2015.0132.
2
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?肝硬化患者初发和复发性结节的超声造影特征:应采用哪些血管标准?
Ultraschall Med. 2013 Jun;34(3):280-7. doi: 10.1055/s-0033-1335024. Epub 2013 Apr 24.
3
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.使用钆塞酸二钠增强磁共振成像和扩散加权磁共振成像对肝炎后肝硬化患者小肝细胞癌(≤2.0 cm)诊断标准的验证
Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12.
4
Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2.肝硬化肝脏的磁共振成像:肝细胞癌的诊断及治疗反应评估 - 第2部分
Radiol Bras. 2017 Mar-Apr;50(2):115-125. doi: 10.1590/0100-3984.2015.0140.
5
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
6
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.对比成像技术诊断肝硬化患者非规律监测下的肝细胞癌。
Ann Hepatol. 2019 Mar-Apr;18(2):318-324. doi: 10.1016/j.aohep.2018.09.002. Epub 2019 Apr 17.
7
Magnetic resonance imaging of the cirrhotic liver: An update.肝硬化肝脏的磁共振成像:最新进展
World J Hepatol. 2015 Mar 27;7(3):468-87. doi: 10.4254/wjh.v7.i3.468.
8
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
9
Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity.将钆贝葡胺增强磁共振成像的肝胆期纳入肝细胞癌的诊断:在不影响特异性的情况下提高敏感性。
Acta Radiol. 2016 Aug;57(8):923-31. doi: 10.1177/0284185115616291. Epub 2015 Nov 13.
10
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.肝硬化中直径20毫米及以下肝脏结节的诊断:肝细胞癌无创诊断标准的前瞻性验证
Hepatology. 2008 Jan;47(1):97-104. doi: 10.1002/hep.21966.

引用本文的文献

1
Large Scale MRI Collection and Segmentation of Cirrhotic Liver.肝硬化肝脏的大规模磁共振成像采集与分割
Sci Data. 2025 May 28;12(1):896. doi: 10.1038/s41597-025-05201-7.
2
High glypican-1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma.高磷脂酰肌醇蛋白聚糖-1表达是预测肝细胞癌患者临床预后不良的一个预后因素。
Oncol Lett. 2020 Nov;20(5):197. doi: 10.3892/ol.2020.12058. Epub 2020 Sep 4.
3
Diffusion-weighted imaging and apparent diffusion coefficient values for evaluating terminal ileitis in patients with Crohn's disease.

本文引用的文献

1
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.欧洲胃肠道和腹部放射学会关于肝脏磁共振成像及肝脏特异性对比剂临床应用的共识声明。
Eur Radiol. 2016 Apr;26(4):921-31. doi: 10.1007/s00330-015-3900-3. Epub 2015 Jul 21.
2
Magnetic resonance imaging of the cirrhotic liver: An update.肝硬化肝脏的磁共振成像:最新进展
World J Hepatol. 2015 Mar 27;7(3):468-87. doi: 10.4254/wjh.v7.i3.468.
3
Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis.
用于评估克罗恩病患者终末回肠炎的扩散加权成像及表观扩散系数值
Radiol Bras. 2019 Nov-Dec;52(6):361-367. doi: 10.1590/0100-3984.2019.0011.
4
Differential diagnosis between hepatocellular carcinoma and cirrhosis by serum amino acids and acylcarnitines.通过血清氨基酸和酰基肉碱鉴别肝细胞癌与肝硬化
Int J Clin Exp Pathol. 2018 Mar 1;11(3):1763-1769. eCollection 2018.
5
Microvascular invasion in hepatocellular carcinoma: is it predictable with quantitative computed tomography parameters?肝细胞癌中的微血管侵犯:能否通过定量计算机断层扫描参数预测?
Radiol Bras. 2019 Sep-Oct;52(5):287-292. doi: 10.1590/0100-3984.2018.0123.
6
Radiological findings in the liver of a patient with Rendu-Osler-Weber syndrome.一名患有遗传性出血性毛细血管扩张症(Rendu-Osler-Weber综合征)患者肝脏的放射学检查结果。
Radiol Bras. 2019 May-Jun;52(3):200-201. doi: 10.1590/0100-3984.2017.0158.
7
Integrating bilingual musculoskeletal imaging education into radiology and diagnostic imaging residency programs.将双语肌肉骨骼影像学教育纳入放射学和诊断影像学住院医师培训项目。
Radiol Bras. 2018 May-Jun;51(3):162-165. doi: 10.1590/0100-3984.2017.0027.
8
Fat-containing liver lesions: a pictorial review.含脂肪的肝脏病变:图文综述
Radiol Bras. 2018 Jan-Feb;51(1):52-57. doi: 10.1590/0100-3984.2016.0147.
9
Computed tomography angiography study of variations of the celiac trunk and hepatic artery in 100 patients.100例患者腹腔干和肝动脉变异的计算机断层血管造影研究
Radiol Bras. 2018 Jan-Feb;51(1):32-36. doi: 10.1590/0100-3984.2016.0179.
10
Magnetic resonance imaging ancillary features used in Liver Imaging Reporting and Data System: An illustrative review.肝脏影像报告和数据系统中使用的磁共振成像辅助特征:实例综述。
World J Radiol. 2018 Feb 28;10(2):9-23. doi: 10.4329/wjr.v10.i2.9.
肝细胞癌:多排 CT 和 MR 成像的诊断性能——系统评价和荟萃分析。
Radiology. 2015 Apr;275(1):97-109. doi: 10.1148/radiol.14140690. Epub 2015 Jan 5.
4
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.肝细胞癌的CT与MR成像诊断及分期:第二部分。细胞外对比剂、肝胆对比剂及辅助成像特征。
Radiology. 2014 Oct;273(1):30-50. doi: 10.1148/radiol.14132362.
5
MRI of hepatocellular carcinoma: an update of current practices.磁共振成像在肝细胞癌诊断中的应用:现状更新。
Diagn Interv Radiol. 2014 May-Jun;20(3):209-21. doi: 10.5152/dir.2014.13370.
6
Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase.肝硬化患者行平扫及钆贝葡胺增强 MRI 动态及肝胆期扫描对肿瘤性及非肿瘤性不典型结节的诊断预测因素。
AJR Am J Roentgenol. 2013 Mar;200(3):553-62. doi: 10.2214/AJR.12.8818.
7
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.器官共享联合网络/器官获取与移植网络肝脏移植分配新政策:肝细胞癌肝脏成像、诊断、分类及报告的标准化
Radiology. 2013 Feb;266(2):376-82. doi: 10.1148/radiol.12121698.
8
Quantitatively defining washout in hepatocellular carcinoma.定量定义肝细胞癌中的洗脱。
AJR Am J Roentgenol. 2013 Jan;200(1):84-9. doi: 10.2214/AJR.11.7171.
9
Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.肝硬化中102个结节的对比增强磁共振成像:与移植肝脏组织学结果的相关性
Abdom Imaging. 2013 Apr;38(2):290-6. doi: 10.1007/s00261-012-9952-9.
10
MR imaging of hypervascular lesions in the cirrhotic liver: a diagnostic dilemma.肝硬化肝脏富血管性病变的磁共振成像:诊断难题。
Radiographics. 2012 May-Jun;32(3):767-87. doi: 10.1148/rg.323115131.